Serotype incidence and antibiotic susceptibility of Streptococcus pneumoniae causing invasive disease in Scotland, 1999-2002

Journal of Medical Microbiology

Volumn 54, Issue 4, 2005, Pages 327-331

  Denham, B C ^a   Clarke, S C ^a,b,c  

^a Scottish Meningococcus P   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c Finchdean House ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; ERYTHROMYCIN; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; DISEASE ACTIVITY; DISEASE SEVERITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; UNITED KINGDOM; VACCINATION;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; INCIDENCE; MICROBIAL SENSITIVITY TESTS; PNEUMOCOCCAL INFECTIONS; SCOTLAND; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 16844364325     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.45718-0     Document Type: Article

References (13)

1. Bos, J. M., Rumke, H., Welte, R. & Postma, M. J. (2003). Epidemiologic impact and cost-effectiveness of universal infant vaccination with a 7-valent conjugated pneumococcal vaccine in the Netherlands. Clin Ther 25, 2614-2630.
2. Clarke, S. C., Diggle, M. A. & Edwards, G. F. (2001). Surveillance of pneumococcal disease in Scotland. SCIEH Weekly Report 35, 2.
3. Gertz, R. E., Jr, McEllistrem, M. C., Boxrud, D. J. & 8 other authors (2003). Clonal distribution of invasive pneumococcal isolates from children and selected adults in the United States prior to 7-valent conjugate vaccine introduction. J Clin Microbiol 41, 4194-4216.
4. Kyaw, M. H., Clarke, S., Edwards, G. F., Jones, I. G. & Campbell, H. (2000). Serotypes/groups distribution and antimicrobial resistance of invasive pneumococcal isolates: implications for vaccine strategies. Epidemiol Infect 125, 561-572.
5. Kyaw, M. H., Jones, I. G. & Campbell, H. (2002a). Prevalence of penicillin non-susceptible invasive pneumococcal disease in the elderly in Scotland, 1992-99. Scand J Infect Dis 34, 559-563.
6. Kyaw, M. H., Clarke, S., Jones, I. G. & Campbell, H. (2002b). Incidence of invasive pneumococcal disease in Scotland, 1988-99. Epidemiol Infect 128, 139-147.
7. Kyaw, M. H., Christie, P., Clarke, S. C., Mooney, J. D., Ahmed, S., Jones, I. G. & Campbell, H. (2003). Invasive pneumococcal disease in Scotland, 1999-2001: use of record linkage to explore associations between patients and disease in relation to future vaccination policy. Clin Infect Dis 37, 1283-1291.
8. Mohan, P. V. & Heath, P. T. (2001). Pneumococcal disease in childhood. Hosp Med 62, 406-409.
9. Muhlemann, K., Matter, H. C., Tauber, M. G. & Bodmer, T. (2003). Nationwide surveillance of nasopharyngeal Streptococcus pneumoniae isolates from children with respiratory infection, Switzerland, 1998-1999. J Infect Dis 187, 589-596.
10. Obaro, S. & Adegbola, R. (2002). The pneumococcus: carriage, disease and conjugate vaccines. J Med Microbiol 51, 98-104.
11. Skoczynska, A. & Hryniewicz, W. (2003). Genetic relatedness, antibiotic susceptibility, and serotype distribution of Streptococcus pneumoniae responsible for meningitis in Poland, 1997-2001. Microb Drug Resist 9, 175-182.
12. Smart, L. E. (1986). Serotyping of Streptococcus pneumoniae strains by coagglutination. J Clin Pathol 39, 328-331.
13. Whitney, C. G., Farley, M. M., Hadler, J. & 10 other authors (2003). Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348, 1737-1746.